Publication Cover
Archives of Andrology
Journal of Reproductive Systems
Volume 47, 2001 - Issue 3
411
Views
6
CrossRef citations to date
0
Altmetric
Research Article

EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON SERUM PSA IN PATIENTS WITH KLINEFELTER SYNDROME

, , , , , , & show all
Pages 173-176 | Published online: 09 Jul 2009

  • Andrews PE, Young CYF, Montgomery BT, Tindall DI (1992): Tumor-promoting phorbol ester downregulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line. Cancer Res 52:1525-1529.
  • Bangma CH, Niemer QHJ, Grobbee DE, Schroder FH (1996): Transrectal ultrasonic volumetry of the prostate: in vivo comparison of different methods. Prostate 28:107-110.
  • Behre HM, Bohmeyer J, Nieschlag E (1994): Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol 40:341-349.
  • Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petras JA, Andriole GL (1991): Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156-1161.
  • Douglas TH, Connelly RR, McLeod DG, Erickson SJ, Barren R, Murphy GP (1995): Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men. J Surg Oncol 59:246-250.
  • Gormely GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS (1992): The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 327:1185-1191.
  • Hanash KA, Mostofi KF (1992): Androgen effect on prostate specific antigen secretion. J Surg Oncol 49:202-204.
  • Jackson JA, Waxman J, Spiekerman AM (1989): Prostatic complications of testosterone replacement therapy. Arch Intern Med 149:2365-2366.
  • Lindau RL (1974): Does testosterone therapy for impotence increase risk of prostatic carcinoma? JAMA 229:1357-1361.
  • Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC (1991): Influence of age and endocrine factors on volume of benign prostate hyperplasia. J Urol 145:405-409.
  • Roberts JT, Essenhigh DM (1986): Adenocarcinoma of prostate in 40-year-old body-builder. Lancet 2:742.
  • Sasagawa I, Nakada T, Kazama T, Terada T. Katayama T (1989): Testosterone replacement therapy and prostate/seminal vesicle volume in Klinefelter's syndrome. Arch Androl 22:245-249.
  • Snyder PL, Lawrence DA (1980): Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 51:1335-1339.
  • Scamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N (1989): Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate, II: Radical prostatectomy treated patients. J Urol 141:1076-1083.
  • Wallace EM, Pye SD, Wild SR, Wu FCW (1993): Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception. Int J Androl 16:35-40.
  • Weber JF, Oesterling JE, Peters CA (1989): The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol 141:987-992.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.